KUALA LUMPUR: RHB Research is maintaining a Buy on Genting Malaysia as it believes the company has reached its inflection point, where almost all its facilities have re-opened, boosted by encouraging business recovery.
In its research note issued on Tuesday, it said as the world moves closer to a potential Covid-19 vaccine, GentingM is a clear beneficiary of a cyclical recovery.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!